2nd International Conference on
Oncology and Cancer Research

Prof. Giuseppe Spriano, an esteemed figure in Otorhinolaryngology, leads as Director at Humanitas University, Milan. With a distinguished career marked by groundbreaking research and compassionate patient care, he embodies excellence in the field. His expertise extends globally, shaping the future of head and neck medicine through leadership and mentorship. His legacy resonates through his impactful contributions to academia and clinical practice.

Prof. Alexis Andrew Miller, a distinguished Radiation Oncologist, serves at the Illawarra Cancer Institute in Wollongong, Australia. With a passion for advancing cancer treatment, He is renowned for his expertise in radiation therapy, contributing significantly to patient care and research in the field.

Dr. Sarin Kitpanit, an esteemed Radiation Oncologist specializing in Head and Neck cancers, leads the Particle Therapy unit at MedPark Hospital in Thailand. Recognized for his pioneering work in advanced radiation techniques, She is dedicated to improving outcomes for patients through precision medicine and compassionate care.

Dr. Loren Mell, a distinguished Tenured Professor at UCSD, California, serves as Vice-Chair of Clinical & Translational Research. Renowned for his leadership as Co-Leader of the Moores Cancer Center Head/Neck Disease Team and Section Chief of Head/Neck Cancer, He is dedicated to advancing oncological care through research and patient-centered approaches.

Dr. Kenneth Jensen, an accomplished Associate Professor at Aarhus University Hospital, Denmark, is affiliated with the Danish Centre for Particle Therapy. His expertise extends to serving as a valued member of DAHANCA'S Radiotherapy Quality Assurance Group, demonstrating a commitment to excellence in cancer care and research.

"Margaret Hjorth is currently the inaugural National Director of Nursing and Allied Health Nursing Director for Icon Cancer Centre – Australia and has a clear strategic role in the development of cancer nurses across Australia. Margaret has also held the position of chair of the Cancer Nurses Society of Australia (CNSA) Radiation Oncology Nurses Specialty Practice Network (RONSPN). This role has enabled Margaret to network with expert clinicians from across Australia to initiate and lead change in the way we care for this patient group. Margaret has a strong interest in developing resources and professional development opportunities for all cancer nurses. Margaret has developed practice principles for caring for patients undergoing radiation therapy with the aim to standardise patient care and ensure positive patient experience and patient outcomes regardless of where treatment is received. These principles will now form part of the national standards in radiation oncology within Australia. Margaret is committed to advancing nursing practice through the ongoing development and education of health professionals within the specialty and beyond."

Bradford has a PhD in Medical Biochemistry-Oncology from the Roswell Park Cancer Institute, Division of SUNY at Buffalo School of Medical and Biomedical Sciences. She is the inventor of the various patents that AccuTheranostics holds. She was awarded the Award for Excellence in Research from the American Federation for Clinical Research, has authored many scientific papers and book chapters, and been an invited speaker at various international scientific meetings. Dr. Bradford is a member of many major professional cancer organizations including, ASCO, AACR and AAAS. As Chief Scientific Officer, Dr. Bradford guides the day-to-day research directives as well as the clinical laboratory operations.

Dental School University of Medicine and Dentistry of New Jersey 110 Bergen Street Newark